Sheri McMahon

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors”.

A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors

The Oncologist(2023)10.1093/oncolo/oyac244

N/A

0.588DataRank · unranked

16 citations

Nicholas Tschernia, Julius Strauss, Ravi A. Madan, Fatima Karzai, Marijo Bilušić +14 more

Evaluating biomarkers in metastatic castration-resistant prostate cancer patients treated with enzalutamide: PSA, circulating tumor cell counts, AR-V7 status and radiographic progression.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e17569

N/A

0DataRank · unranked

1 citations

Fatima Karzai, Jennifer L. Marté, Marijo Bilušić, Sheri McMahon, Julius Strauss +13 more

First-in-human phase I/II trial of PRGN-2009 vaccine as monotherapy or with bintrafusp alfa in patients with recurrent/metastatic (R/M) human papillomavirus (HPV)-associated cancers (HPVC) and as neoadjuvant/induction therapy in locoregionally advanced (LA) HPV oropharyngeal (OP) and sinonasal (SN) squamous cell cancer (SCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps6092

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Nyall R. London, Renee N. Donahue, Caroline Jochéms +14 more

483 Initial safety results and immune responses induced by a novel human papillomavirus (HPV)-specific gorilla adenovirus immunotherapy vaccine, PRGN-2009, in patients with advanced HPV-associated cancers

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.483

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Renee N. Donahue, Caroline Jochéms, Seth M. Steinberg +11 more

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

The Oncologist(2022)10.1093/oncolo/oyab046

N/A

0DataRank · unranked

51 citations

Yo-Ting Tsai, Benjamin A. Weinberg, Renee N. Donahue, Shruti U. Gandhy, Margaret E. Gatti‐Mays +14 more

Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide

European Urology Oncology(2023)10.1016/j.euo.2023.09.010

N/A

0DataRank · unranked

3 citations

Fatima Karzai, Marijo Bilušić, Sheri McMahon, Lisa M. Cordes, Jennifer L. Marté +12 more

PSA progression compared to radiographic or clinical progression in metastatic castration-resistant prostate cancer patients treated with enzalutamide.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.105

N/A

0DataRank · unranked

7 citations

Fatima Karzai, Jennifer L. Marté, Marijo Bilušić, Sheri McMahon, Julius Strauss +10 more

Phase I evaluation of PRGN-2009 alone and in combination with bintrafusp alfa in patients (pts) with recurrent/metastatic (R/M) HPV-associated cancers (HPV-C).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2628

N/A

0DataRank · unranked

11 citations

Julius Strauss, Jason M. Redman, Danielle M. Pastor, Evrim Türkbey, Renee N. Donahue +11 more